Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 1 2Phase 4 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 9Gastrointestinal 8Lymphoid 3Breast 3Head & Neck 2Genitourinary 2Other solid neoplasm 1Other neoplasm 1Other hematologic neoplasm 1Other 1Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Squamous Intraepithelial Lesions 1Precancerous Conditions 1Papillomavirus Infections 1Atypical Squamous Cells of the Cervix 1

Interventions

Paclitaxel 233Carboplatin 217Bevacizumab 139Cisplatin 136pembrolizumab 89Gemcitabine 69olaparib 54Docetaxel 47Topotecan 44Radiotherapy 43liposomal doxorubicin 41Taxes 41niraparib 38Cyclophosphamide 36Doxorubicin 30Drug Therapy 29Letrozole 28Nivolumab 27Magnetic Resonance Spectroscopy 25Immunoglobulin G 25Disulfides 24Oxaliplatin 23Albumin-Bound Paclitaxel 23durvalumab 22apatinib 21Etoposide 21Brachytherapy 21lenvatinib 20camrelizumab 20Specimen Handling 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Folic Acid × Gynecologic × Clear all
NCT00703196 2015-10-08

Folic Acid Clinical Trial for the Prevention of Cervical Cancer

University of Alabama at Birmingham

Phase 2 Completed
368 enrolled
GynecologicOther neoplasm

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions, Papillomavirus Infections, Atypical Squamous Cells of the Cervix

Data powered by HemOnc (CC BY 4.0) Colophon âš¡